Science Corporation has secured EU regulatory approval for its innovative brain-computer interface, designed to restore vision lost due to age-related macular degeneration.
The device is known as PRIMA
Jul 23, 2026
10:09 am
What's the storyScience Corporation, a start-up specializing in innovative brain-computer interfaces (BCI), has received approval from Europe's medical device regulator to market its vision-restoring device.
The device, known as PRIMA, is designed to restore some sight lost due to age-related macular degeneration.
"The thing that the space needs is a company making $100 million a year of revenue," Science Corp. CEO Max Hodak said.
Science Corp's PRIMA retinal implant gains EU approval, marking progress in neurotech market. Aims for $100M annual revenue to…
Science describes PRIMA as an "investigational" retinal implant designed to combat vision loss caused by GA and AMD. For the time…
US neural engineering company Science Corporation has received EU approval for its vision repair medtech implant.
Science Corp. Announces European Commercial Launch of PRIMA, the Only Treatment to Restore Functional Central Vision to Patients…
Science Corp's Prima retina implant restores some sight and has won EU approval, the first US brain-implant device to reach…
